Liens UNIL

FR EN

Unisciences

You are here: UNIL > Unisciences

Search
- Search
- Show the data
  from to

Stefano Fontana

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil

48 publications

2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2006 | 2005 | 2004 | 2001 | 1994 |

2023

Epidemiology of HEV Infection in Blood Donors in Southern Switzerland.

Fontana S., Ripellino P., Niederhauser C., Widmer N., Gowland P., Petrini O., Aprile M., Merlani G., Bihl F., 2023/09/22. Microorganisms, 11 (10) p. 2375. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_096A486FDD95]

Développements récents en hématologie, Partie 2

Duchosal Michel A., Alberio Lorenzo, Angelillo-Scherrer Anne, Arber Caroline, Balabanov Stefan, Blum Sabine, Bttcher Steffen, Buser Andreas, Cairoli Anne, Chalandon Yves et al., 2023/08/23. Forum Médical Suisse ‒ Swiss Medical Forum.

[DOI][serval:BIB_E9D38C229944]

Développements récents en hématologie, Teil 1

[DOI][serval:BIB_BEEE6D0FAED7]

Prevalence of anti-tick-borne encephalitis virus (TBEV) antibodies in Swiss blood donors in 2014-2015.

Ackermann-Gäumann R., Eyer C., Vock M., Gowland P., Tinguely C., Leib S.L., Bori M., Buser A., Fontana S., Thierbach J. et al., 2023/03. Blood transfusion = Trasfusione del sangue, 21 (2) pp. 100-109. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_7B01A2676532]

2022

Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell-depleting agents.

Gachoud D., Pillonel T., Tsilimidos G., Battolla D., Dumas D., Opota O., Fontana S., Vollenweider P., Manuel O., Greub G. et al., 2022/11. British journal of haematology, 199 (4) pp. 549-559. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_801AF06A907A]

2021

How donor selection criteria can be evaluated with limited scientific evidence: lessons learned from the TRANSPOSE project.

Mikkelsen C., Mori G., van Walraven S.M., Castrén J., Zahra S., MacLennan S., Seidel K., Fontana S., Veropalumbo E., Cannata L. et al., 2021/03. Vox sanguinis, 116 (3) pp. 342-350. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_1C7B4A6D2986]

Putting the spotlight on donation-related risks and donor safety - are we succeeding in protecting donors?

Mikkelsen C., Mori G., van Walraven S.M., Castrén J., Zahra S., MacLennan S., Seidel K., Fontana S., Veropalumbo E., Cannata L. et al., 2021/03. Vox sanguinis, 116 (3) pp. 313-323. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_AA81C3DB4FA7]

2020

The effects of intravenous iron supplementation on fatigue and general health in non-anemic blood donors with iron deficiency: a randomized placebo-controlled superiority trial.

Keller P., von Känel R., Hincapié C.A., da Costa B.R., Jüni P., Erlanger T.E., Andina N., Niederhauser C., Lämmle B., Fontana S., 2020/08/26. Scientific reports, 10 (1) p. 14219. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_D6914949B7D8]

2018

Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016

Niederhauser Christoph, Widmer Nadja, Hotz Magdalena, Tinguely Caroline, Fontana Stefano, Allemann Gabrielle, Borri Mauro, Infanti Laura, Sarraj Amira, Sigle Jörg et al., 2018/08/30. Eurosurveillance, 23 (35).

[URN][DOI][WoS][Pmid][serval:BIB_C94A6E7A4E44]

Platelet Transfusion Induces Alloimmunization to D and Non-D Rhesus Antigens.

Reckhaus J., Jutzi M., Fontana S., Bacher V.U., Vogt M., Daslakis M., Mansouri Taleghani B., 2018/05. Transfusion medicine and hemotherapy, 45 (3) pp. 167-172. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_EF881AED8714]

Editorial: Transfusion Medicine and Blood.

Prudent M., Tissot J.D., Fontana S., Niederhauser C., 2018. Frontiers in medicine, 5 p. 355. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_48D6D65303DC]

Red blood cell use in Switzerland: trends and demographic challenges.

Volken T., Buser A., Castelli D., Fontana S., Frey B.M., Rüsges-Wolter I., Sarraj A., Sigle J., Thierbach J., Weingand T. et al., 2018/01. Blood transfusion = Trasfusione del sangue, 16 (1) pp. 73-82. Peer-reviewed.

[DOI][Pmid][serval:BIB_EC413CB25095]

2017

West Nile Virus preparedness plan to ensure safe blood components in Switzerland: a risk-based approach

Niederhauser C., Fontana S., Glauser A., Steinemann C., Koller A., 2017/05. ISBT Science Series, 12 (2) pp. 314-321.

[DOI][serval:BIB_1B943FF2EFD1]

2016

Generalizability of Dutch Prediction Models for Low Hemoglobin Deferral: A Study on External Validation and Updating in Swiss Whole Blood Donors.

Baart A.M., Fontana S., Tschaggelar A., Heymans M.W., de Kort W.L., 2016/11. Transfusion medicine and hemotherapy, 43 (6) pp. 407-414. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_88070EA8F142]

Too Many Blood Donors - Response Bias in the Swiss Health Survey 2012.

Volken T., Bänziger A., Buser A., Castelli D., Fontana S., Frey B.M., Sarraj A., Sigle J., Thierbach J., Weingand T. et al., 2016/11. Transfusion medicine and hemotherapy, 43 (6) pp. 400-406. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_60B333B98F4F]

Parvovirus B19 Passive Transmission by Transfusion of Intercept® Blood System-Treated Platelet Concentrate

Gowland Peter, Fontana Stefano, Stolz Martin, Andina Nicola, Niederhauser Christoph, 2016. Transfusion Medicine and Hemotherapy, 43 (3) pp. 198-202.

[DOI][WoS][Pmid][serval:BIB_C5A491943E2F]

2014

Predicting 5-fluorouracil toxicity: DPD genotype and 5,6-dihydrouracil:uracil ratio.

Sistonen J., Büchel B., Froehlich T.K., Kummer D., Fontana S., Joerger M., van Kuilenburg A.B., Largiadèr C.R., 2014/09. Pharmacogenomics, 15 (13) pp. 1653-1666. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_C7A2246A564A]

A Simple Guideline Reduces the Need for Red Blood Cell Transfusions in Swiss Hospitals: A Prospective, Multicentre, Before-and-After Study in Elective Hip and Knee Replacement.

Fontana S., de la Cuadra C., Müller U., Schmid P., Perler M., Luginbühl M., Taleghani B.M., 2014. Transfusion Medicine and Hemotherapy, 41 (3) pp. 182-188. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_594F74C1C08A]

Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responses.

Adam J., Wuillemin N., Watkins S., Jamin H., Eriksson K.K., Villiger P., Fontana S., Pichler W.J., Yerly D., 2014. Plos One, 9 (4) pp. e95339. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_2882EFAE3000]

Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors.

Stolz M., Tinguely C., Fontana S., Niederhauser C., 2014. Transfusion, 54 (11) pp. 2961-2967. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_45D7C2D6AFBA]

Implementation of a mandatory donor RHD screening in Switzerland.

Crottet S.L., Henny C., Meyer S., Still F., Stolz M., Gottschalk J., Neuenschwander K., Taleghani B.M., Gowland P., Frey B.M. et al., 2014. Transfusion and Apheresis Science, 50 (2) pp. 169-174. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_22032281FE0D]

Molecular RHD screening of RhD negative donors can replace standard serological testing for RhD negative donors.

Gowland P., Gassner C., Hustinx H., Stolz M., Gottschalk J., Tissot J.D., Thierbach J., Maier A., Sigurdardottir S., Still F. et al., 2014. Transfusion and Apheresis Science, 50 (2) pp. 163-168. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_DF8EE2BB43EE]

Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01.

Yun J., Marcaida M.J., Eriksson K.K., Jamin H., Fontana S., Pichler W.J., Yerly D., 2014. Journal of Immunology, 192 (7) pp. 2984-2993. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_EC7FDF086850]

T cells infiltrate the liver and kill hepatocytes in HLA-B(∗)57:01-associated floxacillin-induced liver injury.

Wuillemin N., Terracciano L., Beltraminelli H., Schlapbach C., Fontana S., Krähenbühl S., Pichler W.J., Yerly D., 2014. American Journal of Pathology, 184 (6) pp. 1677-1682. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_992F130ACCF0]

Transfusion efficacy of apheresis platelet concentrates irradiated at the day of transfusion is significantly superior compared to platelets irradiated in advance.

Julmy F., Ammann R.A., Fontana S., Taleghani B.M., Hirt A., Leibundgut K., 2014. Transfusion Medicine and Hemotherapy, 41 (3) pp. 176-181. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_4E9BCA0DC3B0]

2013

Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response.

Yun J., Mattsson J., Schnyder K., Fontana S., Largiadèr C.R., Pichler W.J., Yerly D., 2013. Clinical and Experimental Allergy, 43 (11) pp. 1246-1255. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B1B08720EB6C]

Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention.

Sigle J.P., Thierbach J., Infanti L., Muriset M., Hunziker G., Chassot K., Niederhauser C., Gowland P., Holbro A., Sunic K. et al., 2013. Vox Sanguinis, 105 (3) pp. 244-252. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_49813DBDAC83]

HLA haplotype determines hapten or p-i T cell reactivity to flucloxacillin.

Wuillemin N., Adam J., Fontana S., Krähenbühl S., Pichler W.J., Yerly D., 2013. Journal of Immunology, 190 (10) pp. 4956-4964. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_E44B00933FD2]

Serologic and molecular investigations of DAR1 (weak D Type 4.2), DAR1.2, DAR1.3, DAR2 (DARE), and DARA.

Lejon Crottet S., Haer-Wigman L., Gowland P., Fontana S., Niederhauser C., Hustinx H., 2013. Transfusion, 53 (11 Suppl 2) pp. 3000-3008. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_579FB61DFCAD]

Seroprevalence of hantavirus infections in Switzerland in 2009: difficulties in determining prevalence in a country with low endemicity.

Engler O., Klingstrom J., Aliyev E., Niederhauser C., Fontana S., Strasser M., Portmann J., Signer J., Bankoul S., Frey F. et al., 2013. Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 18 (50) p. 20660.

[WoS][Pmid][serval:BIB_6B5652341281]

2012

Avidity determines T-cell reactivity in abacavir hypersensitivity.

Adam J., Eriksson K.K., Schnyder B., Fontana S., Pichler W.J., Yerly D., 2012. European Journal of Immunology, 42 (7) pp. 1706-1716. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_AD82250129BE]

2011

Platelet Recruitment during Multiple Donor Platelet Apheresis Differs between Cell Separators.

Fontana S., Keller P., Taleghani B.M., 2011. Transfusion Medicine and Hemotherapy, 38 (3) pp. 195-198. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_2D25A9446E67]

Recruitment of platelets, white blood cells, and hematopoietic progenitor cells during high-yield plateletpheresis.

Fontana S., Rados L., Schmid P., Leibundgut E.O., Taleghani B.M., 2011. Transfusion, 51 (9) pp. 2034-2043. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_85B96B7ED932]

2010

500 ml of blood loss does not decrease non-invasive tissue oxygen saturation (StO2) as measured by near infrared spectroscopy - A hypothesis generating pilot study in healthy adult women.

Jeger V., Jakob S.M., Fontana S., Wolf M., Zimmermann H., Exadaktylos A.K., 2010. Journal of Trauma Management and Outcomes, 4 p. 5. Peer-reviewed.

[DOI][Pmid][serval:BIB_B72C322034ED]

Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region.

Stolz M., Tinguely C., Graziani M., Fontana S., Gowland P., Buser A., Michel M., Canellini G., Züger M., Schumacher P. et al., 2010. Transfusion, 50 (12) pp. 2695-2706. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_EEB9B0010BBA]

2009

Molecular basis of the Rh antigen RH48 (JAL).

Hustinx H., Poole J., Bugert P., Gowland P., Still F., Fontana S., Scharberg E.A., Tilley L., Daniels G., Niederhauser C., 2009. Vox Sanguinis, 96 (3) pp. 234-239. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_875EA12B7211]

Prospective, Paired Crossover Comparison of the in vitro Quality of Red Blood Cells Collected by the Automate for Blood Collection Device or by a Conventional Method.

Fontana S., Weingand T., Maier A., Taleghani B.M., 2009. Transfusion Medicine and Hemotherapy, 36 (4) pp. 289-292. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_AF259E83BAAA]

Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs.

Julmy F., Ammann R.A., Taleghani B.M., Fontana S., Hirt A., Leibundgut K., 2009. Transfusion, 49 (1) pp. 21-33. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_871F711106CC]

2008

Effects of high-yield thrombocytapheresis on the quality of platelet products.

Julmy F., Ammann R.A., Mansouri Taleghani B., Fontana S., Hirt A., Leibundgut K., 2008. Transfusion, 48 (3) pp. 442-450. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_55A6B36A8DA8]

2006

Progenitor cell recruitment during individualized high-flow, very-large-volume apheresis for autologous transplantation improves collection efficiency.

Fontana S., Groebli R., Leibundgut K., Pabst T., Zwicky C., Taleghani B.M., 2006. Transfusion, 46 (8) pp. 1408-1416. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_30F05F482381]

Prospective, paired crossover comparison of multiple, single-needle plateletpheresis procedures with the Amicus and Trima Accel cell separators.

Fontana S., Mordasini L., Keller P., Taleghani B.M., 2006. Transfusion, 46 (11) pp. 2004-2010. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_192A3F92B33C]

2005

Oxaliplatin-induced immune pancytopenia.

Taleghani B.M., Meyer O., Fontana S., Ahrens N., Novak U., Borner M.M., Salama A., 2005. Transfusion, 45 (5) pp. 704-708. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B1F2487EC721]

2004

Implementation of the JACIE standards for a haematopoietic progenitor cell transplantation programme: a cost analysis.

Zahnd D., Leibundgut K., Zenhäusern R., Pabst T., Fontana S., Schneider R., Tobler A., Zwicky C., 2004. Bone Marrow Transplantation, 34 (10) pp. 847-853. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_710909CA4A52]

Molecular and serologic tracing of a transfusion-transmitted hepatitis A virus.

Gowland P., Fontana S., Niederhauser C., Taleghani B.M., 2004. Transfusion, 44 (11) pp. 1555-1561. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_A7E15D1E37A6]

Plasma therapy in thrombotic thrombocytopenic purpura: review of the literature and the Bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency.

Fontana S., Kremer Hovinga J.A., Studt J.D., Alberio L., Lämmle B., Taleghani B.M., 2004. Seminars in Hematology, 41 (1) pp. 48-59. Peer-reviewed.

[WoS][Pmid][serval:BIB_872CB3D86E64]

Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura.

Kremer Hovinga J.A., Studt J.D., Demarmels Biasiutti F., Solenthaler M., Alberio L., Zwicky C., Fontana S., Taleghani B.M., Tobler A., Lämmle B., 2004. Haematologica, 89 (3) pp. 320-324. Peer-reviewed.

[WoS][Pmid][serval:BIB_E11A4CDDCA61]

2001

Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease.

Fontana S., Gerritsen H.E., Kremer Hovinga J., Furlan M., Lämmle B., 2001. British Journal of Haematology, 113 (1) pp. 100-102. Peer-reviewed.

[WoS][Pmid][serval:BIB_87B1AFB386E8]

1994

Treatment and prognosis of centrocytic (mantle cell) lymphoma: a retrospective analysis of twenty-six patients treated in one institution.

Zucca E., Fontana S., Roggero E., Pedrinis E., Pampallona S., Cavalli F., 1994. Leukemia and Lymphoma, 13 (1-2) pp. 105-110. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_96EC70C24A5C]

Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11

Contact
Annuaires

Informations légales
Plan du site
Edition